Article Details

Bayer, Amgen back ReCode's plan to broaden genetic medicine's reach | BioPharma Dive

Retrieved on: 2022-06-29 15:40:43

Tags for this article:

Click the tags to see associated articles and topics

Bayer, Amgen back ReCode's plan to broaden genetic medicine's reach | BioPharma Dive. View article details on hiswai:

Excerpt

But while mRNA is the star, neither of the shots would work without the fatty shells that protect them. Known as lipid nanoparticles, these shells ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up